8 hasil untuk "Francesca Collu"
Menampilkan 1–8 · 0,87 detik · RSS
-
Artikel Jurnal Teks lengkap
Exploring Binding Properties of Agonists Interacting with a δ-Opioid Receptor
Ligand-receptor interactions are at the basis of the mediation of our physiological responses to a large variety of ligands, such as hormones, neurotransmitters and environmental stimulants, and their tuning represents the goal of a large variety of therapies. Several molecular details of these…
Juga tersedia di: DOAJ
-
Artikel Jurnal Teks lengkap
Functional Rotation of the Transporter AcrB: Insights into Drug Extrusion from Simulations
The tripartite complex AcrAB-TolC is the major efflux system in Escherichia coli. It extrudes a wide spectrum of noxious compounds out of the bacterium, including many antibiotics. Its active part, the homotrimeric transporter AcrB, is responsible for the selective binding of substrates and energy…
Juga tersedia di: DOAJ
-
Artikel Jurnal
MOLECULAR DYNAMICS COMPUTER SIMULATIONS OF MULTIDRUG RND EFFLUX PUMPS
Over-expression of multidrug efflux pumps of the Resistance Nodulation Division (RND) protein super family counts among the main causes for microbial resistance against pharmaceuticals. Understanding the molecular basis of this process is one of the major challenges of modern biomedical research…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Investigating Ebola virus pathogenicity using molecular dynamics
Abstract Background Ebolaviruses have been known to cause deadly disease in humans for 40 years and have recently been demonstrated in West Africa to be able to cause large outbreaks. Four Ebolavirus species cause severe disease associated with high mortality in humans. Reston viruses are the only…
-
Artikel Jurnal
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface
While targeted therapy against HER2 is an effective first-line treatment in HER2+ breast cancer, acquired resistance remains a clinical challenge. The pseudokinase HER3, heterodimerisation partner of HER2, is widely implicated in the resistance to HER2-mediated therapy. Here, we show that…